View all dosages and compare prices:

💉 Buy Ozempic — all dosages →
💉FlexTouch pen injector · Novo Nordisk

Buy Ozempic 0.5 mg (4 doses)

in Ukraine · Pen injector with NovoFine+ needles · Novo Nordisk

Therapeutic dose · 4 injections · NovoFine Plus needles included

0.5 mg
4.8·39 reviews
8 900

4 injections per pen · NovoFine+ needles included

Out of stock

First therapeutic dose — main phase of the program from week 5.

Active ingredientсемаглутід (semaglutide)
Dosage0.5 mg
Doses per pen4 doses (4 weeks)
FormFlexTouch Pen Injector
Course4+ weeks (maintenance)
👨‍⚕️

Specialist support included

A personal DOZA specialist supports you throughout the entire course — from the first consultation to results. No extra fees: support is already included in the product price.

🇫🇷

Original Ozempic FR version by Novo Nordisk

DOZA works exclusively with original Ozempic French version — the most regulated EU market with minimal risk of counterfeiting. Manufacturer — Novo Nordisk (headquarters Bagsværd, Denmark). Each FlexTouch pen has a unique 2D Data Matrix serial number per EU FMD standard — upon request we provide a photo of the serial number before shipping so you can verify it against the code on the packaging upon receipt. Approved by FDA and EMA for type 2 diabetes treatment.

Free specialist consultation

Benefits of Ozempic 0.5 mg (4 doses)

  • First therapeutic dose — main phase of the program from week 5 after 0.25 mg titration
  • 4 injections + 4 NovoFine Plus 32G × 4 mm needles included — complete month of therapy
  • Original Novo Nordisk · FR version · serial number photo on request
  • GLP-1 receptor activation: appetite reduction, satiety feeling, delayed gastric emptying
  • 1 subcutaneous injection per week — convenient regular regimen
  • SUSTAIN studies documented stable weight loss (≈4 kg over 30–40 weeks combined with program)

Ozempic 0.5 mg (4 doses) — detailed description

Ozempic 0.5 mg — original FlexTouch pen from Novo Nordisk, first therapeutic (maintenance) dose of semaglutide.

The 0.5 mg dose is the first level of therapeutic effect. At this dose, most patients already experience significant appetite reduction and begin losing weight. According to the STEP-1 study, participants on semaglutide lost an average of 14.9% body weight over 68 weeks.

How Ozempic 0.5 mg (4 doses) Works — Semaglutide Mechanism of Action

Semaglutide is a GLP-1 receptor agonist. At the 0.5 mg dose, the therapeutic effect becomes complete:

1. Appetite reduction — you naturally eat 20–30% less without feeling hungry.

2. Delayed gastric emptying — prolonged feeling of satiety after each meal.

3. Improved glucose metabolism — normalization of blood sugar levels.

At the 0.5 mg dose, results become noticeable: weight loss of 1.5–3 kg per month with balanced nutrition.

Dosage

Maintenance dose: 0.5 mg once weekly.

Prescribed after 4 weeks on the starting dose of 0.25 mg. For most patients, this dose provides effective weight loss and appetite reduction.

If after 4+ weeks on the 0.5 mg dose the result is insufficient, a specialist may recommend increasing to 1.0 mg.

Subcutaneous injection (abdomen, thigh, or upper arm). Same day of the week, any time of day.

Clinical research

Ozempic (semaglutide 0.5 mg) — FDA approved 2017 for diabetes, 2021 for weight management (Wegovy). The /research page contains the full evidence base: STEP-1 / SUSTAIN-6 / FDA prescribing information.

View full clinical research database →

Titration protocol to 0.5 mg (semaglutide)

Weeks 1–4
0.25 mg

Starting dose

Weeks 5+
0.5 mg← this dose

First therapeutic dose

Injection once weekly, subcutaneous (abdomen, thigh or upper arm). Expected weight loss at 0.5 mg: 3–5% over 30 weeks (based on clinical studies).

Who is Ozempic 0.5 mg for

  • First therapeutic dose for glucose control (type 2 diabetes)
  • Patients who tolerate 0.25 mg well
  • Maintenance dose for patients with mild excess weight

Ozempic 0.5 mg — compared to other doses

  • 0.5 mg is effective for glycemic control
  • Less effective for weight loss than 1.0 mg (HbA1c reduction ~1.5%)
  • Fewer side effects than on 1.0 mg

FAQ About Ozempic 0.5 mg (4 doses)

Anastasia Shapoval

1 FlexTouch pen (1.5 ml solution) + 4 disposable NovoFine Plus 32G × 4 mm needles. The pen is designed for 4 doses of 0.5 mg — for 4 weeks at 1 injection per week.

Anastasia Shapoval

Metabolic Programs and Weight Control Specialist

Ready to start?

Free specialist consultation

DOZA client reviews for Ozempic 0.5 mg (4 doses)

★★★★★Maryna K.January 2026

Ozempic 0.5 mg (4 doses) — results visible in just 2 weeks. Delivery in thermal packaging, everything neat. DOZA — thank you!

★★★★★Oleksandr P.February 2026

I order Ozempic 0.5 mg (4 doses) through DOZA — original product, fast delivery across Ukraine. The consultant helped with dosage selection.

All client results →

Before/after photos · numbers · timelines · reviews

🏆

Ozempic 0.5 mg (4 doses) buy in Ukraine — DOZA

Ozempic 0.5 mg (4 doses) — original FlexTouch pen injector FR version by Novo Nordisk. Buy Ozempic 0.5 mg (4 doses) in Ukraine through the DOZA online service with delivery in 1–2 days in a thermal box (cold chain 2–8°C). Therapeutic dose · 4 injections · NovoFine Plus needles included.

Price of Ozempic 0.5 mg (4 doses) — 8 900 ₴ (≈ 2 225 ₴ per injection). For detailed information about dosage and suitability, consult a DOZA specialist.

Semaglutide (the active ingredient of Ozempic) is a GLP-1 receptor agonist that reduces appetite, controls glucose levels, and promotes sustained weight loss. STEP clinical trials showed up to 15% body weight loss over 68 weeks.

Buy Ozempic 0.5 mg (4 doses) with delivery across Ukraine (Kyiv, Kharkiv, Odesa, Dnipro, Lviv). Cold chain 2–8°C. Free specialist consultation. We respond 24/7.

Information verified

Anastasia Shapoval

Metabolic Programs and Weight Control Specialist

Olena Kovalchuk

Medical Reviewer, Endocrinologist

Updated

⚠️ This information is for educational purposes only and does not constitute advertising of medicinal products. We recommend obtaining an individual specialist consultation before starting the program. Results may vary depending on individual characteristics. Ozempic® is a registered trademark of Novo Nordisk A/S.